List of Mountain View Pharmaceuticals patents | 5 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7927852 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates	Patent 7927852 was granted and assigned to Mountain View Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.	‌ Mountain View Pharmaceuticals	United States Patent and Trademark Office	7927852	April 19, 2011
‌ US Patent 8129330 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof	Patent 8129330 was granted and assigned to Mountain View Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.	‌ Mountain View Pharmaceuticals	United States Patent and Trademark Office	8129330	March 6, 2012
‌ US Patent 7229810 Polymer conjugates of proteinases	Patent 7229810 was granted and assigned to Mountain View Pharmaceuticals on June, 2007 by the United States Patent and Trademark Office.	‌ Mountain View Pharmaceuticals	United States Patent and Trademark Office	7229810	June 12, 2007
‌ US Patent 7927589 PEG-urate oxidase conjugates and use thereof	Patent 7927589 was granted and assigned to Mountain View Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.	‌ Mountain View Pharmaceuticals	United States Patent and Trademark Office	7927589	April 19, 2011
‌ US Patent 9125880 Polymer conjugates of interferon-beta with enhanced biological potency	Patent 9125880 was granted and assigned to Mountain View Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.	‌ Mountain View Pharmaceuticals	United States Patent and Trademark Office	9125880	September 8, 2015